LLLI - Lamperd Less Lethal, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue124.85764.08633.35
Cost of Revenue33.8252.96433.386
Gross Profit91.03711.121-0.037
Operating Expenses
Research Development---
Selling General and Administrative381.533250.703755.494
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-344.404-299.546-780.06
Income from Continuing Operations
Total Other Income/Expenses Net0.67-1.13822.038
Earnings Before Interest and Taxes-343.734-300.684-758.021
Interest Expense65.5274.861214.846
Income Before Tax-409.261-305.545-972.867
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-409.261-305.545-972.867
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-409.261-305.545-972.867
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-409.261-305.545-972.867